Quarterly report pursuant to Section 13 or 15(d)

Recapitalization - Additional Information (Details)

v3.22.2.2
Recapitalization - Additional Information (Details) - Tyme Therapeutics, Inc.
$ in Millions
Sep. 16, 2022
USD ($)
shares
Business Acquisition [Line Items]  
Shares issued | shares 7,500,000
Number of options and warrants issued | shares 733,545
Transaction costs | $ $ 3.1
Severance costs | $ $ 4.5